Literature DB >> 8249301

Transcriptional control of the equine herpesvirus 1 immediate early gene.

J B Lewis1, Y G Thompson, G B Caughman.   

Abstract

Transient expression assays measuring induction of an equine herpesvirus 1 (EHV-1) immediate early (IE) promoter construct, pIE beta gal, were used to examine trans-induction of the IE gene (IR1) promoter by superinfection with intact EHV-1 (Kentucky A strain), uv-inactivated EHV-1, or EHV-1 stocks highly enriched for defective interfering particles (DIPs), and by cotransfection with plasmids containing EHV-1 DNA fragments. Our results confirm reports by others in that the IE promoter can be induced by both intact and uv-inactivated EHV-1 and provide evidence that DIP-rich virus stocks also possess transinducing activity. Furthermore, IE promoter activity was induced by cotransfection of the promoter construct with either of two plasmids containing restriction enzyme DNA fragments that span ORF12, the putative EHV-1 homolog of the herpes simplex virus 1 (HSV-1) alpha-trans-inducing factor (alpha-TIF) gene, UL48, or by cotransfection with an isolated DNA fragment containing only ORF12, while no transactivation was associated with plasmids linearized by restriction enzyme digestion at a single site within ORF12. These data indicate that, despite its predicted lack of an acidic carboxy terminus (a region essential in HSV-1 alpha-TIF for trans-inducing activity), the EHV-1 ORF12 product is a functional alpha-TIF.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8249301     DOI: 10.1006/viro.1993.1658

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  19 in total

1.  Differences in determinants required for complex formation and transactivation in related VP16 proteins.

Authors:  M Grapes; P O'Hare
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  Characterization of cis-acting elements required for autorepression of the equine herpesvirus 1 IE gene.

Authors:  Seongman Kim; Gan Dai; Dennis J O'Callaghan; Seong Kee Kim
Journal:  Virus Res       Date:  2012-01-14       Impact factor: 3.303

3.  Conformational alteration of Oct-1 upon DNA binding dictates selectivity in differential interactions with related transcriptional coactivators.

Authors:  V Misra; S Walter; P Yang; S Hayes; P O'Hare
Journal:  Mol Cell Biol       Date:  1996-08       Impact factor: 4.272

4.  Bovine herpesvirus 1 U(L)3.5 interacts with bovine herpesvirus 1 alpha-transinducing factor.

Authors:  N Lam; G J Letchworth
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

5.  Characterization of the trans-activation properties of equine herpesvirus 1 EICP0 protein.

Authors:  D E Bowles; S K Kim; D J O'Callaghan
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

6.  The EHV-1 UL4 protein that tempers viral gene expression interacts with cellular transcription factors.

Authors:  Yunfei Zhang; Robert A Charvat; Seong K Kim; Dennis J O'Callaghan
Journal:  Virology       Date:  2013-11-21       Impact factor: 3.616

7.  The extreme carboxyl terminus of the equine herpesvirus 1 homolog of herpes simplex virus VP16 is essential for immediate-early gene activation.

Authors:  G D Elliott
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

8.  Protein and DNA elements involved in transactivation of the promoter of the bovine herpesvirus (BHV) 1 IE-1 transcription unit by the BHV alpha gene trans-inducing factor.

Authors:  V Misra; A C Bratanich; D Carpenter; P O'Hare
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

9.  Detection and intracellular localization of equine herpesvirus 1 IR1 and IR2 gene products by using monoclonal antibodies.

Authors:  G B Caughman; J B Lewis; R H Smith; R N Harty; D J O'Callaghan
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

10.  Identification and characterization of the ICP22 protein of equine herpesvirus 1.

Authors:  V R Holden; G B Caughman; Y Zhao; R N Harty; D J O'Callaghan
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.